None listed
Conditions
Interventions
Drug : The present study was conducted prospectively and the patient visited the day before surgery or the morning to explain the purpose of the study and then proceeded with the written consent of th
Fresenius Kabi, France)
Rocuronium 0.6 mg / kg was administered intravenously.
Anesthesia maintained during rocuronium 5 ~ 12 mcg / kg / min Continuous sedation to maintain muscle relaxation.
- Group
Sponsors
Bundang CHA General Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: - American Society of Anesthesiologists physical status (ASA) 1-2 - Elective surgery - Patients undergoing POEM (Peroral endoscopic myomectomy) surgery - Patients who recieved written informed consent to participate to this study
Exclusion criteria
Exclusion criteria: - Patients who refused to participate in the study - Patients with chronic renal failure, severe cardiopulmonary compromise - Patients with allergies to the drug - Patients who are deemed unfit to participate in the examination by the medical staff for other reasons (Pregnancy, long-term use of analgesics or sedatives, history of alcoholism or drug addiction) - Patients who can not voluntarily agree
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postoperative nausea and vomiting | — |
Secondary
| Measure | Time frame |
|---|---|
| Length of postanesthetic care unit;Length of hospital stay;GERD incidence;Patient satisfaction;PONV related adverse events;, POEM related adverse events;Mortality;ICU admission rate | — |
Countries
Korea, Republic of
Contacts
Public ContactYun-Sic Bang
Bundang CHA General Hospital
Outcome results
None listed